maxillary carcinoma, nasal cavity and paranasal sinus malignancy.pdf
TRANSCRIPT
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
1/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com1
Nasal cavity and paranasal sinus malignancy
(For more topics, visitwww.nayyarENT.com)
EPIDEMIOLOGY
< 1 % of all neoplasms 3% of tumors of upper aero digestive tract Incidence 0.5-1 / 100,000/ yr 5th -6th decade M:F 2:1 Avg delay between the first symptom and diagnosis six mths Origin (Scott Brown)
o Maxillary sinusmost common (55 %)o Nasal cavity 35 %o Ethmoid sinuses 9 %o Frontal and sphenoid sinuses (1 %)
AETIOLOGY
Wood workerso 70 times increased incidence particularly in ethmoido African mahogany most dangerouso Biologically active compounds in wood dust impair mucociliary clearance and
predispose to carcinogenesis
o Hardwood exposureadenocarcinomao Soft wood exposure squamous cell carcinoma
Nickelo Relative risk >250o Interval between exposure to nickel and tumor 18 to 36 years
Chromium
Leather industry Polycyclic hydrocarbons Smokingsynergistic with wood dust Aflatoxin (found in certain foods and dust) Mustard gas Thorotrast (thorium dioxide used in paints for watch dials) Radiation Viral EBV, HPV Use of snuff (cocaine)
http://www.nayyarent.com/http://www.nayyarent.com/http://www.nayyarent.com/http://www.nayyarent.com/ -
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
2/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com2
Genetic role suggested but not provenOhngren line
Running from the medial canthus of orbit to angle of mandible Separates tumours into two groups
o Those that developed above the lineo Those that developed below it
Ohngren suggestedo Superiorly based cancers more aggressive and poorly differentiatedo Tumours arising from below line more amenable to treatment
With newer imaging & surgical techniques, no longer used nowLymphatic drainage
Lymphatic drainage of nose and paranasal sinuses relatively scanty Two lymphatic pathways
o Anterior Anteroinferior part of nasal cavity and skin of vestibule Drain to facial, parotid and submandibular lymph nodes - the first
echelon nodes
These drain into the upper deep cervical chaino Posterior
Remainder of nose and the paranasal sinuses Pathway which runs anterior to the Eustachian tube to first echelon
nodes - the retropharyngeal lymph nodes
Further drain to upper deep cervical chainPATTERNS OF TUMOUR SPREAD
Local spreado Tend to fill sinus cavity before eroding bony wallso
Periosteum,perichondrium and dura seem to act as a temporary barrierso Bone of the antronasal wall, canine fossa and orbital floor very thin easily
destroyed
o Only 25 percent of maxillary sinus carcinomas are contained within theantrum at time of presentation
Regional spreado Lymphatic spread apparent in 25-35 % of patients at some time during the
course of their disease
o Only 10 % have nodal disease at time of presentationo Submandibular and jugulodigastric nodes most commonly involved
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
3/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com3
o Bilateral lymph node involvement likely when tumor near midline Distant spread
o Adenocarcinomas 18%o Squamous cell carcinomas 10%o Common sites bone, brain, liver, lung, skin
SYMPTOMS
Nasal: 50%o Obstruction, epistaxis, rhinorrhea
Oral symptoms: 25-35%o Pain, trismus, alveolar ridge fullness, malocclusion, erosion
Ocular: 25%o Epiphora, diplopia, proptosis
Facialo Paresthesias, asymmetry
Neck mass Ears
o Hearing loss, serous otitis mediaPHYSICAL FINDINGS
Nasal, facial, or intraoral massoIntranasal mass
Often necrotic, but polypoid mucosa may obscureoFacial swellingantral tumor erodes into cheekoWidening of the upper alveolar ridgeoLoose teethoPalatal mass and ulceration
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
4/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com4
ProptosisCranial nerve deficits
oCN II, III, IV, VIoCN V ( V1 and V2)
Complete H&N exam and EndoscopyDiagnostic Assessment
CT scano Three-dimensional image of the lesiono Bone destruction, orbital & intracranial involvement
MRIo Better soft tissue delineationo Ability to differentiate between tumor bulk and retained secretionso Combined with CT for planning surgery for sinus neoplasms
Angiographyo If the lesion demonstrates enhancement during initial CT studyo If it approximates carotid systemo In evaluation of unusual tumors involving the sphenoid sinus and skull baseo In vascular tumors for assessment of tumor extent, feeding vessels and in
combination with embolization
Ultrasoundo B-mode scanning orbital masses
PETo Follow-up after concomitant chemoradiationo
Assessing presence of metastatic disease Endoscopy and Biopsy
o Punch biopsyo Chances of bleedingo Tumors contained within the sinus cavities should be biopsied transnasally
Dental / prosthetic consultationWorkup for distant metastasis
CXR PA view USG abdomen
Workup for surgery
Hb, TLC, DLC INR, Platelet count Bld Grouping Urine RE,ME BS F/PP LFT, RFT, Electrolytes ECG Lipid profile
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
5/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com5
STA
GIN
G
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
6/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com6
(For more topics, visitwww.nayyarENT.com)
http://www.nayyarent.com/http://www.nayyarent.com/http://www.nayyarent.com/ -
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
7/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com7
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
8/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com8
(For more topics, visitwww.nayyarENT.com)
http://www.nayyarent.com/http://www.nayyarent.com/http://www.nayyarent.com/ -
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
9/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com9
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
10/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com10
TREATMENT
General principles
Most patients have very advanced disease at presentation
All investigations & accurate staging Choice between treatment for cure and palliation Options for patients potentially curable
o Surgeryo Radiotherpyo Chemoradiotherapyo Combinationso Infusion & perfusion techniques (see combined answer)
Management Algorithms (as per NCCN 2011 guidelines)
Maxillary carcinoma
(For more topics, visitwww.nayyarENT.com)
http://www.nayyarent.com/http://www.nayyarent.com/http://www.nayyarent.com/ -
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
11/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com11
Ethmoidal Carcinoma
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
12/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com12
Recurrent / Persistent disease
Surgical options
External Ethmoidectomy Inferior Medial Maxillectomy Medial Maxillectomy Radical Maxillectomy Craniofacial Resections Extended Craniofacial Resection Minimally Invasive Approaches
Surgical approaches
Endoscopic Lateral rhinotomy Transoral/transpalatal Midfacial degloving Weber-Fergusson Combined craniofacial approach
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
13/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com13
External Ethmoidectomy
Indicationso Removal of benign tumors of the ethmoidal regiono Approach to biopsy and drainage for tumors of sphenoethmoidal region and
medial orbit Bony Excision medial orbital wall and the ethmoidal labyrinth Surgical Approach incision on the lateral wall of the nose Benefits allows excellent cosmesis and preservation of functional tissue Limitations
o For limited tumors (middle turbinate)o Tendency to form a fistula to nasal cavity on irradiation
Inferior Medial Maxillectomy
Indications
o Resection of medial wall of the antrum and inferior turbinateo Most often used for inverted papilloma
Bony Excision marginso Laterally vertical line dropped from the infraorbital forameno Inferiorlyfloor of the noseo Superiorlylacrimal fossa and the middle meatuso Posteriorlydorsal end of the inferior turbinate
Surgical Approach Lateral rhinotomy Benefits
o Adequate exposure and resection for limited tumorso Preserve functional tissueo Provide a very acceptable cosmetic result
Limitationsprovides en bloc removal of limited areaMedial Maxillectomy
Indication larger benign or intermediate tumors involving theentire lateral nasal wall but without extension to the orbit,
anterior cranial fossa, lateral maxilla, or alveolus
Bony Excision lateral nasal wall, including all turbinatetissue, and the contents of the ethmoid and maxillary sinuses
Surgical Approach WeberFergusson with Lynch extensionand lip split
Bony cutso Removal of ant maxillary wall medial to infra orbital
foramen
o Orbital cut from inferior rim carried medially to lamina papyraceao Nasomaxillary suture line cut extending from cut 2 into pyriform apertureo Cut in lateral nasal wall near floor upto post wall of maxillary sinuso Vertical cut from post. nasal floor to post end of sup turbinate & post
ethmoidal cells
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
14/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com14
Benefiten bloc resection with little cosmetic deformity LimitationsRemoval of all turbinate tissue results in an abnormal nasal cavity,
often requiring chronic management of crusting
Total Maxillectomy
Indications advanced carcinoma of maxilla Bony Excision removal of maxilla along with nasal bone, the ethmoid sinus, and in
some instances, the pterygoid plates
Surgical Approach Weber Fergusson with a Defenbach (subciliary) extension Bony cuts
o Zygomatico maxillary suture lineo Orbital floor & medial orbital wallo Naso maxillary suture lineo Hard palateo Pterygoid process
Can be combined with orbital exentration Preformed obturator support for packing Benefits When supplemented by irradiation, cure rate 30% (Cummings) Limitations Even when orbital exenteration is included inadequate resection if
ethmoidal roof, orbital apex or pterygoid region involved
Therefore, careful evaluation & planning required before surgeryCraniofacial Frontoethmoidectomy
Indications en bloc resectionfor tumors of the ethmoidal and
frontal regions
Bony Excisiono Anterior cranium
(including the frontal
sinus)
o Floor of anterior cranialfossa
o Ethmoido +/- Eyeo Nasal septum
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
15/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com15
Benefitso Provides direct visualization of the cribriform plate and fovea ethmoidaliso Potential for en bloc removalo Provides wide exposure to allow effective repair of dural tearso Allows intraoperative irradiation or placement of a radioactive implant
LimitationsIf tumor extends to sphenoid sinus, cavernous or transdurally, en blocresection cannot be achieved
Extended Craniofacial Resection
IndicationsExtensive tumors involving the anterior skull base including pterygoidplates
Bony Marginso Posterior limits
Foramen ovale Foramen rotundum ICA
o Remaining margins as for craniofacial frontoethmoidectomy and totalmaxillectomy
o Surgical Approach Bicoronal and anterior or lateral facial incisions Closure split-galea flap to cover dura
o Team neurosurgeon + otolaryngologisto Benefits Thorough exposure and complete excision of otherwise
unresectable tumors
o Contrindicationsclear-cut pterygoid plate erosion and cranial nerveinvasion
Supplemental Management in Extended Craniofacial Resection
Intraoperative iodine seed implantationo Adenoid cystic carcinoma more beneficialo Undifferentiated carcinoma and squamous cell carcinoma less optimistic
Reconstruction (for detailed reconstruction see maxillectomy presentation)o Radial forearmo Rectus abdominis musculocutaneous flapso Latissimus dorsi flap
Radiotherapy
Conventionalo 66-70 Gy (2.0 Gy/fraction; daily Monday-Friday) in 7 weekso Neck Uninvolved nodal stations: 44-64 Gy (1.6-2.0 Gy/fraction)
Concurrent chemoradiotherapyo Primary and gross adenopathy: 70 Gy (2.0 Gy/fraction)o Neck Univolved nodal stations: 44-64-Gy (1.6-2.0 Gy/fraction)
Postoperative RT
o Primary 6066 Gy (2.0 Gy / fraction)
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
16/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com16
o Neck Involved nodal stations: 60-66 Gy (2.0 Gy/fraction) Uninvolved nodal station: 44-64 Gy (1.6-2.0 Gy/fraction)
o Preferred interval between resection and postoperative RT is
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
17/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com17
Intermediate Neoplasmso Inverted Papillomaso Meningiomaso Hemangiomaso Hemangiopericytoma
Malignant lesionso Squamous cell carcinomao Adenocarcinomao Adenoid cystic carcinomao Olfactory neuroblastomao Sinonasal undifferentiated carcinomao Lymphomao Mucoepidermoid carcinomao Melanomao Osteogenic sarcomao Fibrosarcomao Chondrosarcomao Rhabdomyosarcomao Metastatic tumors
Squamous cell carcinoma
Most common tumor (80%) Location:
o Maxillary sinus (70%)o Nasal cavity (20%) 90% have local invasion by presentation Lymphatic drainage:
o First echelon: retropharyngeal nodeso Second echelon: subdigastric nodes
Surgical resection with postoperative radiationAdenocarcinoma
2nd most common malignant tumor Present most often in the superior portions Strong association with occupational exposures High grade
o Solid growth pattern with poorly defined marginso 30% present with metastasis
Low gradeo Uniform and glandular with less incidence of perineural invasion/metastasis
-
7/30/2019 Maxillary carcinoma, Nasal cavity and paranasal sinus malignancy.pdf
18/18
Dr. Supreet Singh Nayyar, AFMC 2011
www.nayyarENT.com18
Adenoid Cystic Carcinoma
3rd most common site